Financial anchor year: FY22. Margin and revenue are as filed for FY22. Every tile below states its own fiscal year; nothing is carried forward or estimated.
The read
A dialysis facility in TX. It ran an operating surplus of 36.9% in FY22 on $0.2M of operating revenue. Only a single comparable reporting year is available, so trend context is limited.
Operating margin · FY22
+36.9%
vs dialysis facilities95th pctl of 7,741
Days cash on hand
Not available
vs dialysis facilities—
Total operating revenue · FY23
$0.2M
vs dialysis facilities2nd pctl
Total margin · incl. nonoperating · FY22
+36.9%
vs dialysis facilities96th pctl
Where DIALYSIS 452501 sits among dialysis facilities
Operating margin · FY24 pool · n = 7,741 of 7,741 filed
Each point is one dialysis facility in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The dialysis facility median is +11.9%. Descriptive context only, not a ranking.
One dialysis facilityDIALYSIS 452501dialysis facility median
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.
Operating margin
+36.9% (FY22)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
+36.9% (FY22)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
Not reported in this filing
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
0.98× (FY22)
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
Not reported in this filing
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
Not reported in this filing
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line item
FY21
FY22
FY23
Patient revenue
2,485
1,776
191
Total operating revenue
2,485
1,776
191
Total operating expenses
1,478
1,121
548
Operating income
1,006
655
(357)
Operating margin %
+40.5%
+36.9%
-186.9%
Other non-operating, net
0
0
0
Net income
1,006
655
(357)
Net income %
+40.5%
+36.9%
-186.9%
HCRIS CMS-265 cost report · $ thousands · FY20–FY24 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
A condensed balance sheet is not shown for this dialysis facility: the public cost report does not carry substantive balance-sheet detail (assets, liabilities, and net assets that reconcile) for this provider. The income statement and ratio exhibit above are the reliable financial view here. We lead with those rather than render a hollow table.
Trajectory
Cost-report basis · 5 reporting years
Operating margin
Days cash on hand
The county this dialysis facility serves
Location, TX
Median household income
$74.1K
vs $82.1K US · $59.7K rural median
Poverty rate
14.0%
vs 12.5% US · 14.3% rural median
Uninsured
21.6%
vs 8.6% US · 8.4% rural median
Age 65+
11.5%
vs 16.8% US · 20.6% rural median
Fair or poor health
22.6%
self-reported, adults · CDC PLACES
Primary-care shortage
Designated
HRSA HPSA
Economic context: 5.1% of county personal income is Medicare/Medicaid medical benefits; 11.8% arrives as government transfers (BEA, 2022).
The Board Briefing$1,000
The free profile shows the record. The Board Briefing tells you what changed, what matters, and what your board should ask. 35+ pages, built entirely from public sources, no client data required. Delivered within 2 business days. If we cannot deliver the published scope for your facility, you pay nothing.
